Michael M Song Advances in Neuroblastoma Research Congress 2016

Abstracts this author is presenting:

• Cell lines (CLs) and patient derived xenografts (PDXs) established from post-mortem neuroblastoma samples display heterogeneity in sensitivity to chemotherapeutic agents commonly utilized in the treatment of high-risk neuroblastoma patients. — Poster Session 2 with wine & cheese
• High MYCN, low MYC, low CERS4, and low anti-apoptotic BCL2 gene family expression are associated with sensitivity to fenretinide in neuroblastoma cell lines and PDXs — Parallel 11 Biomarkers and Novel Approaches